Baylis Medical Technologies
Private Company
Total funding raised: $105M
Overview
Baylis Medical Technologies is a privately held, commercial-stage medical device company founded in 1986 and headquartered in Mississauga, Canada (with a strong U.S. presence). The company specializes in innovative access solutions for endovascular procedures, with flagship products like the PowerWire® RF guidewire family and Passport® Steerable Sheath. It operates through two divisions: Endovascular (product commercialization) and Design and Manufacturing Services (contract services). With a global commercial footprint and a focus on complex, high-value procedures, Baylis is positioned in the growing market for advanced vascular access and crossing devices.
Technology Platform
Proprietary radiofrequency (RF) energy and steerable sheath platforms for vascular access and crossing of chronic total occlusions (CTOs) and complex anatomy.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Baylis competes in the vascular access and CTO crossing segment against major players like Boston Scientific (CrossBoss, Stingray), Medtronic, and Abbott, as well as specialized firms like Philips (Volcano). Its differentiation lies in its focused RF energy platform for the most challenging occlusions, but it must continually innovate against these well-established competitors.